1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Competent Cells Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemically Competent Cells
1.2.3 Electrocompetent Cells
1.3 Market by Application
1.3.1 Global Competent Cells Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Subcloning & Routine Cloning
1.3.3 Phage Display Library Construction
1.3.4 Toxic/Unstable DNA Cloning
1.3.5 High-Throughput Cloning
1.3.6 Protein Expression
1.3.7 Mutagenesis
1.3.8 Single-Stranded DNA Production
1.3.9 Bacmid Creation
1.3.10 Cre-Lox Recombination (PIR1/PIR2)
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Competent Cells Market Perspective (2016-2027)
2.2 Competent Cells Growth Trends by Regions
2.2.1 Competent Cells Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Competent Cells Historic Market Share by Regions (2016-2021)
2.2.3 Competent Cells Forecasted Market Size by Regions (2022-2027)
2.3 Competent Cells Industry Dynamic
2.3.1 Competent Cells Market Trends
2.3.2 Competent Cells Market Drivers
2.3.3 Competent Cells Market Challenges
2.3.4 Competent Cells Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Competent Cells Players by Revenue
3.1.1 Global Top Competent Cells Players by Revenue (2016-2021)
3.1.2 Global Competent Cells Revenue Market Share by Players (2016-2021)
3.2 Global Competent Cells Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Competent Cells Revenue
3.4 Global Competent Cells Market Concentration Ratio
3.4.1 Global Competent Cells Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Competent Cells Revenue in 2020
3.5 Competent Cells Key Players Head office and Area Served
3.6 Key Players Competent Cells Product Solution and Service
3.7 Date of Enter into Competent Cells Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Competent Cells Breakdown Data by Type
4.1 Global Competent Cells Historic Market Size by Type (2016-2021)
4.2 Global Competent Cells Forecasted Market Size by Type (2022-2027)
5 Competent Cells Breakdown Data by Application
5.1 Global Competent Cells Historic Market Size by Application (2016-2021)
5.2 Global Competent Cells Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Competent Cells Market Size (2016-2027)
6.2 North America Competent Cells Market Size by Type
6.2.1 North America Competent Cells Market Size by Type (2016-2021)
6.2.2 North America Competent Cells Market Size by Type (2022-2027)
6.2.3 North America Competent Cells Market Size by Type (2016-2027)
6.3 North America Competent Cells Market Size by Application
6.3.1 North America Competent Cells Market Size by Application (2016-2021)
6.3.2 North America Competent Cells Market Size by Application (2022-2027)
6.3.3 North America Competent Cells Market Size by Application (2016-2027)
6.4 North America Competent Cells Market Size by Country
6.4.1 North America Competent Cells Market Size by Country (2016-2021)
6.4.2 North America Competent Cells Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Competent Cells Market Size (2016-2027)
7.2 Europe Competent Cells Market Size by Type
7.2.1 Europe Competent Cells Market Size by Type (2016-2021)
7.2.2 Europe Competent Cells Market Size by Type (2022-2027)
7.2.3 Europe Competent Cells Market Size by Type (2016-2027)
7.3 Europe Competent Cells Market Size by Application
7.3.1 Europe Competent Cells Market Size by Application (2016-2021)
7.3.2 Europe Competent Cells Market Size by Application (2022-2027)
7.3.3 Europe Competent Cells Market Size by Application (2016-2027)
7.4 Europe Competent Cells Market Size by Country
7.4.1 Europe Competent Cells Market Size by Country (2016-2021)
7.4.2 Europe Competent Cells Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Competent Cells Market Size (2016-2027)
8.2 Asia-Pacific Competent Cells Market Size by Type
8.2.1 Asia-Pacific Competent Cells Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Competent Cells Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Competent Cells Market Size by Type (2016-2027)
8.3 Asia-Pacific Competent Cells Market Size by Application
8.3.1 Asia-Pacific Competent Cells Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Competent Cells Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Competent Cells Market Size by Application (2016-2027)
8.4 Asia-Pacific Competent Cells Market Size by Region
8.4.1 Asia-Pacific Competent Cells Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Competent Cells Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Competent Cells Market Size (2016-2027)
9.2 Latin America Competent Cells Market Size by Type
9.2.1 Latin America Competent Cells Market Size by Type (2016-2021)
9.2.2 Latin America Competent Cells Market Size by Type (2022-2027)
9.2.3 Latin America Competent Cells Market Size by Type (2016-2027)
9.3 Latin America Competent Cells Market Size by Application
9.3.1 Latin America Competent Cells Market Size by Application (2016-2021)
9.3.2 Latin America Competent Cells Market Size by Application (2022-2027)
9.3.3 Latin America Competent Cells Market Size by Application (2016-2027)
9.4 Latin America Competent Cells Market Size by Country
9.4.1 Latin America Competent Cells Market Size by Country (2016-2021)
9.4.2 Latin America Competent Cells Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Competent Cells Market Size (2016-2027)
10.2 Middle East & Africa Competent Cells Market Size by Type
10.2.1 Middle East & Africa Competent Cells Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Competent Cells Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Competent Cells Market Size by Type (2016-2027)
10.3 Middle East & Africa Competent Cells Market Size by Application
10.3.1 Middle East & Africa Competent Cells Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Competent Cells Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Competent Cells Market Size by Application (2016-2027)
10.4 Middle East & Africa Competent Cells Market Size by Country
10.4.1 Middle East & Africa Competent Cells Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Competent Cells Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Merck KGaA
11.1.1 Merck KGaA Company Details
11.1.2 Merck KGaA Business Overview
11.1.3 Merck KGaA Competent Cells Introduction
11.1.4 Merck KGaA Revenue in Competent Cells Business (2016-2021)
11.1.5 Merck KGaA Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Competent Cells Introduction
11.2.4 Thermo Fisher Scientific Revenue in Competent Cells Business (2016-2021)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Details
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies Competent Cells Introduction
11.3.4 Agilent Technologies Revenue in Competent Cells Business (2016-2021)
11.3.5 Agilent Technologies Recent Development
11.4 Takara Bio
11.4.1 Takara Bio Company Details
11.4.2 Takara Bio Business Overview
11.4.3 Takara Bio Competent Cells Introduction
11.4.4 Takara Bio Revenue in Competent Cells Business (2016-2021)
11.4.5 Takara Bio Recent Development
11.5 Promega Corporation
11.5.1 Promega Corporation Company Details
11.5.2 Promega Corporation Business Overview
11.5.3 Promega Corporation Competent Cells Introduction
11.5.4 Promega Corporation Revenue in Competent Cells Business (2016-2021)
11.5.5 Promega Corporation Recent Development
11.6 Beijing TransGen Biotech
11.6.1 Beijing TransGen Biotech Company Details
11.6.2 Beijing TransGen Biotech Business Overview
11.6.3 Beijing TransGen Biotech Competent Cells Introduction
11.6.4 Beijing TransGen Biotech Revenue in Competent Cells Business (2016-2021)
11.6.5 Beijing TransGen Biotech Recent Development
11.7 GeneScript Corporation
11.7.1 GeneScript Corporation Company Details
11.7.2 GeneScript Corporation Business Overview
11.7.3 GeneScript Corporation Competent Cells Introduction
11.7.4 GeneScript Corporation Revenue in Competent Cells Business (2016-2021)
11.7.5 GeneScript Corporation Recent Development
11.8 Yeastern Biotech
11.8.1 Yeastern Biotech Company Details
11.8.2 Yeastern Biotech Business Overview
11.8.3 Yeastern Biotech Competent Cells Introduction
11.8.4 Yeastern Biotech Revenue in Competent Cells Business (2016-2021)
11.8.5 Yeastern Biotech Recent Development
11.9 New England Biolabs
11.9.1 New England Biolabs Company Details
11.9.2 New England Biolabs Business Overview
11.9.3 New England Biolabs Competent Cells Introduction
11.9.4 New England Biolabs Revenue in Competent Cells Business (2016-2021)
11.9.5 New England Biolabs Recent Development
11.10 QIAGEN N.V.
11.10.1 QIAGEN N.V. Company Details
11.10.2 QIAGEN N.V. Business Overview
11.10.3 QIAGEN N.V. Competent Cells Introduction
11.10.4 QIAGEN N.V. Revenue in Competent Cells Business (2016-2021)
11.10.5 QIAGEN N.V. Recent Development
11.11 OriGene Technologies
11.11.1 OriGene Technologies Company Details
11.11.2 OriGene Technologies Business Overview
11.11.3 OriGene Technologies Competent Cells Introduction
11.11.4 OriGene Technologies Revenue in Competent Cells Business (2016-2021)
11.11.5 OriGene Technologies Recent Development
11.12 Lucigen
11.12.1 Lucigen Company Details
11.12.2 Lucigen Business Overview
11.12.3 Lucigen Competent Cells Introduction
11.12.4 Lucigen Revenue in Competent Cells Business (2016-2021)
11.12.5 Lucigen Recent Development
11.13 Zymo Research
11.13.1 Zymo Research Company Details
11.13.2 Zymo Research Business Overview
11.13.3 Zymo Research Competent Cells Introduction
11.13.4 Zymo Research Revenue in Competent Cells Business (2016-2021)
11.13.5 Zymo Research Recent Development
11.14 Bio-Rad Laboratories
11.14.1 Bio-Rad Laboratories Company Details
11.14.2 Bio-Rad Laboratories Business Overview
11.14.3 Bio-Rad Laboratories Competent Cells Introduction
11.14.4 Bio-Rad Laboratories Revenue in Competent Cells Business (2016-2021)
11.14.5 Bio-Rad Laboratories Recent Development
11.15 Bioline
11.15.1 Bioline Company Details
11.15.2 Bioline Business Overview
11.15.3 Bioline Competent Cells Introduction
11.15.4 Bioline Revenue in Competent Cells Business (2016-2021)
11.15.5 Bioline Recent Development
11.16 Delphi Genetics
11.16.1 Delphi Genetics Company Details
11.16.2 Delphi Genetics Business Overview
11.16.3 Delphi Genetics Competent Cells Introduction
11.16.4 Delphi Genetics Revenue in Competent Cells Business (2016-2021)
11.16.5 Delphi Genetics Recent Development
11.17 IBA GmBH
11.17.1 IBA GmBH Company Details
11.17.2 IBA GmBH Business Overview
11.17.3 IBA GmBH Competent Cells Introduction
11.17.4 IBA GmBH Revenue in Competent Cells Business (2016-2021)
11.17.5 IBA GmBH Recent Development
11.18 Cell Applications
11.18.1 Cell Applications Company Details
11.18.2 Cell Applications Business Overview
11.18.3 Cell Applications Competent Cells Introduction
11.18.4 Cell Applications Revenue in Competent Cells Business (2016-2021)
11.18.5 Cell Applications Recent Development
11.19 BioDynamics Laboratory
11.19.1 BioDynamics Laboratory Company Details
11.19.2 BioDynamics Laboratory Business Overview
11.19.3 BioDynamics Laboratory Competent Cells Introduction
11.19.4 BioDynamics Laboratory Revenue in Competent Cells Business (2016-2021)
11.19.5 BioDynamics Laboratory Recent Development
11.20 Scarab Genomics
11.20.1 Scarab Genomics Company Details
11.20.2 Scarab Genomics Business Overview
11.20.3 Scarab Genomics Competent Cells Introduction
11.20.4 Scarab Genomics Revenue in Competent Cells Business (2016-2021)
11.20.5 Scarab Genomics Recent Development
11.21 GCC Biotech
11.21.1 GCC Biotech Company Details
11.21.2 GCC Biotech Business Overview
11.21.3 GCC Biotech Competent Cells Introduction
11.21.4 GCC Biotech Revenue in Competent Cells Business (2016-2021)
11.21.5 GCC Biotech Recent Development
11.22 SMOBIO Technology
11.22.1 SMOBIO Technology Company Details
11.22.2 SMOBIO Technology Business Overview
11.22.3 SMOBIO Technology Competent Cells Introduction
11.22.4 SMOBIO Technology Revenue in Competent Cells Business (2016-2021)
11.22.5 SMOBIO Technology Recent Development
11.23 Edge BioSystems
11.23.1 Edge BioSystems Company Details
11.23.2 Edge BioSystems Business Overview
11.23.3 Edge BioSystems Competent Cells Introduction
11.23.4 Edge BioSystems Revenue in Competent Cells Business (2016-2021)
11.23.5 Edge BioSystems Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
